E. Gonzalez Barca - Institut Català d'Oncologia Hospitalet, University of Barcelona

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Clonality assessment of disseminated MALT lymphoma

D. Fernandez Calvo,M. Condom Esteve,E. Domingo-Domenech,M. Pane Foix, M. Varela Rodriguez, C. Chappuis de Oliveira, J. Hernandez Ganan, S. Mercadal,E. Gonzalez Barca, I. Carro, M. Oliva,C. Aguilera,

VIRCHOWS ARCHIV（2018）

引用0浏览0引用

Effective treatments are required for patients with diffuse large B-cell lymphoma (DLBCL) with primary refractory disease

Q.Q. Salas,E. Domingo Domenech,S. Mercadal,A. Oliveira,C. Aguilera, E. De la Banda,F. Climent,A. Lucas,N. Garcia, C. Baca,A. Fernandez de Sevilla, A. Sureda,

Hematological Oncology（2017）

引用0浏览0引用

Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

A. García-Noblejas, J. Cannata-Ortiz, E. Conde,E. González Barca,N. Gutiérrez,R. Rojas,M.J. Vidal,M.J. Ramírez, A. Jiménez-Ubieto,J.C. García-Ruiz,J. M. Sancho,A. López,

Annals of hematology（2017）

引用4浏览0WOS引用

PROGRESSION-FREE SURVIVAL OF MORE THAN 9 YEARS IN PATIENTS WITH MANTLE CELL LYMPHOMA TREATED IN FIRST LINE WITH TWO CYCLES OF R-HYPERCVAD/MTX/ARA-C FOLLOWED BY TASPE

M. Andrade Campos,S. Mercadal, E. Domingo Domenech, V Paredes Henao,C. Aguilera, A. C. Oliveira, E. De La Banda,F. Climent,R. Parody,A. Fernandez De Sevilla,A. Sureda,E. Gonzalez Barca

HAEMATOLOGICA（2017）

引用0浏览0引用

SHORT COURSE OF R-HYPERCVAD/MTX/ARA-C FOLLOWED BY ASCT AS FIRST-LINE THERAPY IN MANTLE CELL LYMPHOMA PATIENTS PROLONGS PROGRESSION FREE SURVIVAL TO MORE THAN 9 YEARS. SINGLE CENTER EXPERIENCE

M. Andrade-Campos,S. Mercadal,E. Domingo Domenech, V. Paredes Henao,C. Aguilera Gomez, A. Oliveira Ramos, E. de la Banda,F. Climent,R. Parody Porras,A. Fernandez de Sevilla,A. Sureda,E. Gonzalez Barca

HAEMATOLOGICA（2017）

引用0浏览0引用

CD30 expression in diffuse large B-cell lymphoma correlates with non-GCB subtype but does not have prognostic impact in patients treated with first line R-CHOP/R-CHOP-like

Q. Salas,F. Climent,G. Tapia,M. Riasol,S. Mercadal,E. Domingo Domenech,A. Oliveira,M. Moreno-Velázquez,O. Garcia,C. Aguilera,A. Fernandez de Sevilla,A. Sureda,

Hematological Oncology (2017): 290-290

引用1浏览0引用

INCIDENCE OF SECOND NEOPLASMS AND IMPACT ON SURVIVAL IN PATIENTS DIAGNOSED WITH CLL/LBM: PROSPECTIVE ANALYSIS WITH MORE THAN 7 YEARS OF FOLLOW-UP

A. C. Oliveira, E. De La Banda, S. Mercadal,E. Domingo Domenech,E. Alonso, Q. Salas,M. Andrade Campos,A. Fernandez de Sevilla,A. Sureda,E. Gonzalez Barca

HAEMATOLOGICA（2017）

引用0浏览0引用

Short course of R-HyperCVAD/MTX/ARA-C followed by ASCT as first-line therapy in mantle cell lymphoma patients prolongs progression-free survival to more than 9 years

M. Andrade Campos,Santiago Mercadal,E. Domingo Domenech,Viviana Paredes,Carmen Aguilera,Ana-Carolina Oliveira, E. de la Banda,Fina Climent,R Parody,A. Fernandez de Sevilla,Anna Sureda,E. González Barca

Hematological Oncology（2017）

引用0浏览0引用

DIFFUSE LARGE B-CELL LYMPHOMA IN HIGH RISK AAIPI 2-3 YOUNG PATIENTS: CLINICAL PRESENTATION AND SURVIVAL AFTER FIRST LINE STANDARD R-CHOP THERAPY

M. Q. Salas Gay,E. Domingo-Domenech, S. Mercadal, V. Paredes,A. Oliveira,C. Aguilera,F. Climent, M. Encuentra,A. Fernandez de Sevilla,A. Sureda,E. Gonzalez Barca

HAEMATOLOGICA（2016）

引用0浏览0引用

CLINICAL PRESENTATION, PROGNOSTIC FACTORS AND SURVIVAL OF PATIENTS OLDER THAN 80 YEARS DIAGNOSED WITH LARGE CELL LYMPHOMA: A CENTER OF EXPERIENCE

Q. Salas Gay, F. Climent Esteller,E. Domingo-Domenech,S. Mercadal Vilchez, V Paredes Henao, M. Encuentra Marti, C. Aguilera Gomez, A. Comai, T. Canals, S. Mostacedo Marasovic, C. Boque,A. Fernandez de Sevilla,

HAEMATOLOGICA（2015）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn